Michael F. MacLean, Director of Camp4 Therapeutics CAMP, has filed 0 purchases and 17 sales on the open market. Over the past 12 months that comes to a net sale of $471.6K. The latest trade was on 04/01.

MM

MM

Michael F. MacLean

Director

Company

Camp4 Therapeutics CAMP

First filing

23/01/24

Trades

52 trades

Buys / sales

0 / 17

12-month net buying

−$471.6K

Last trade

04/01

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
AB Avidity Biosciences	Open-market sale10b5-1 plan	01/21	01/23	4,542 sh2 trades	$72.45avg.	$329,067.9	−7.1%
AB Avidity Biosciences	Open-market sale10b5-1 plan	01/07	01/09	1,974 sh	$72.23	$142,582.02	−3.0%
AB Avidity Biosciences	Open-market sale10b5-1 plan	25/08/06	25/08/15	30,914 sh	$42.73	$1,320,955.22	−32.0%
AB Avidity Biosciences	Open-market sale10b5-1 plan	25/03/20	25/03/21	7,935 sh	$31.06	$246,461.1	−7.6%
AB Avidity Biosciences	Open-market sale10b5-1 plan	25/01/21	25/01/23	3,287 sh2 trades	$28.59avg.	$93,975.33	−3.0%
AB Avidity Biosciences	Open-market sale10b5-1 plan	24/12/18	24/12/19	11,151 sh	$32.66	$364,191.66	−11.9%
AB Avidity Biosciences	Open-market sale10b5-1 plan	24/11/06	24/11/08	106,319 sh3 trades	$45.56avg.	$4,843,703.45	−53.1%
AB Avidity Biosciences	Open-market sale10b5-1 plan	24/09/23	24/09/23	11,510 sh	$44.00	$506,440	−10.7%
AB Avidity Biosciences	Open-market sale10b5-1 plan	24/06/18	24/06/20	11,228 sh	$39.13	$439,351.64	−16.3%
AB Avidity Biosciences	Open-market sale10b5-1 plan	24/06/12	24/06/14	104,245 sh	$35.72	$3,723,631.4	−70.3%
AB Avidity Biosciences	Open-market sale10b5-1 plan	24/05/14	24/05/16	75,000 sh	$28.28	$2,121,000	−63.0%
AB Avidity Biosciences	Open-market sale10b5-1 plan	24/03/13	24/03/15	40,000 sh	$24.52	$980,800	−47.6%
AB Avidity Biosciences	Open-market sale10b5-1 plan	24/01/22	24/01/23	1,616 sh	$10.13	$16,370.08	−8.7%